Digestive System TRIZ Cases
- 13-Gene Classifier for Colorectal Cancer Risk Stratification
A 13-gene prognostic classifier detects altered gene expression levels in biological samples to identify colorectal cancer patients.
- Crosslinked Hyaluronic Acid Gel for Periosteal Bone Regeneration
Injecting crosslinked hyaluronic acid gel into the periosteum addresses limited bone regeneration by providing stable structural support and hydration.
- Cordyceps Astragalus Composition for Liver Fibrosis Treatment
A pharmaceutical composition combining Cordyceps sinensis mycelium and condensed astragalus powder to treat liver conditions.
- Sodium Thiosulfate Mitoprotection for Hepatic Ischemia Reperfusion Injury
Sodium thiosulfate replaces toxic hydrogen sulfide donors to treat hepatic ischemia reperfusion injury with improved safety and wider therapeutic windows.
- Cinnamomum cassia extract for gastric ulcer treatment
Cinnamomum cassia extract inhibits nitric oxide production to treat gastritis without side effects.
- Anti-Fractalkine Antibody Dosing for Crohn's Disease
Intravenous anti-fractalkine antibody at 10 to 15 mg/kg neutralizes inflammatory signals, resolving intolerance from broad immunosuppression.
- Ammonium Chloride Therapy for Hepatic Failure and Necrosis
Ammonium chloride stimulates liver tissue repair while acid-resistant polymer envelopes prevent gastric irritation during therapy.
- Vedolizumab Dosing via Predictive Biomarker Screening
Baseline serum alpha4beta7 integrin profiling identifies responders to minimize autoantibody development during treatment.
- Fluorescence pH Sensor for Early Dental Caries Detection
Optical fluorescence sensor detects bacterial porphyrin activity to identify early tooth demineralization.
- Oral Chew Modulating Canine Microbiota via Probiotics
Starch-based edible chew delivers probiotics and prebiotics to modulate canine oral microbiota, reducing periodontal disease risk.
- Pinaverium Bromide and Dimethicone Synergy for IBS Treatment
Combining pinaverium bromide with dimethicone creates a synergistic pharmaceutical composition for gastrointestinal relief.
- Alpha4beta7 and IL-23 Inhibitor Combination for IBD Remission
Combining alpha4beta7 and IL-23 inhibitors targets gut inflammation through coordinated immune cell trafficking blockade.
- Levosimendan Repurposing for Liver Cirrhosis Fibrosis
Repurposing levosimendan inhibits hepatic fibrosis and normalizes brain metabolic activity despite poor results from traditional pharmacological treatments.
- Vaccinium Extract Encapsulation for Balanced Intestinal Release
Yeast cell lysate binds vaccinium extract to balance stomach and intestinal release, preventing premature degradation.
- Anti-FasL Antibody Sequence Optimization for Binding Affinity
Targeted amino acid substitutions in anti-FasL antibodies increase binding affinity while maintaining structural stability.